Bibliographic survey of the causal relationship between Cardiovascular diseases and Covid-19
DOI:
https://doi.org/10.33448/rsd-v11i16.37905Keywords:
Cardiomyocytes Injury; SARS-CoV-2; Covid-19.Abstract
This study aims to perform an integrative literature review to understand the causal relationship between cardiovascular diseases and Covid-19 and to point out new updates on the subject. Currently, the world faces the pandemic of coronavirus disease 2019, a severe acute respiratory syndrome caused by coronavirus SARS-CoV-2, having as one of the most frequent pathological consequences cardiovascular diseases. Infection-related myocardial damage can occur due to multiple reasons, including: decreased oxygen levels due to acute respiratory distress syndrome, damage from direct viral invasion of cardiomyocytes with subsequent cell death, microthrombus formation, and a persistent inflammatory state. Viral invasion impairs the contractile function of cardiomyocytes, triggers electrical dysfunction and alters the balance of the Reinnine Angiotensin Aldosterone system. To date, epidemiological studies indicate that a high pathological relationship between Covid-19 and cardiovascular diseases where both pathologies complement each other to generate simultaneous harmful damage. Given the current compelling evidence that myocardial injury intensifies the severity of Covid-19, cardiac management should be a priority for physicians and health professionals. The harmful relationship between SARS-CoV-2 infection and cardiovascular diseases is notorious, but new searches to better understand its etiology are crucial.
References
Akter, F., Mannan, A., Mehedi, H. H., Rob, M. A., Ahmed, S., Salauddin, A., Hossain, M. S., & Hasan, M. M. (2020). Clinical characteristics and short term outcomes after recovery from COVID-19 in patients with and without diabetes in Bangladesh. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14(06), 2031-2038. doi.org/10.1016/j.dsx.2020.10.016
Augustine, R., S, A., Nayeem, A., Salam, S. A., Augustine, P., Dan, P., & Hasan, A. (2022). Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin–angiotensin-aldosterone system (RAAS) dysregulation. Chemico-Biological Interactions, 351. doi.org/10.1016/j.cbi.2021.109738
Bansal, M. (2020). Cardiovascular disease and COVID-19. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14(03), 247-250. doi.org/10.1016/j.dsx.2020.03.013
Brem, F., Chaymae, M., Rasras, H., Merbouh, M., Bouazzaoui, M., Bkiyar, H., Abda, N., Zakaria, B., Ismaili, N., Housni, B., & Ouafi, N. (2022). Acute Myocardial Injury Assessed by High Sensitive Cardiac Troponin Predicting Severe Outcomes and Death in Hospitalized Patients with COVID-19 Infection. Clinical and Applied Thrombosis/Hemostasis, 18. doi.org/10.1177/10760296221090227
Dantas, H. L. de L., Costa, C. R. B., Costa, L. de M. C., Lúcio, I. M. L., & Comassetto, I. (2022). Como elaborar uma revisão integrativa: sistematização do método científico. Revista Recien - Revista Científica de Enfermagem, 12(37), 334–345. doi.org/10.24276/rrecien2022.12.37.334-345.
Fignani, D., Licata, G., Brusco, N., Nigi, L., Grieco, G. E., Marselli, L., Overbergh, L., Gysemans, C., Colli, M. L., & Marchetti, P. (2020). SARS-CoV-2 Receptor Angiotensin I Converting Enzyme Type 2 (ACE2) Is Expressed in Human Pancreatic b-Cells and in the Human Pancreas Microvasculature. Frontiers in endocrinology, 13(11). doi.org/10.3389/fendo.2020.596898
Hoffmann, M., Weber, H., Schroeder, S., Muller, M., Drosten, C., & Pohlmann, S. (2020). SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell, 181, 271-280. doi.org/10.1016/j.cell.2020.02.052
Hung, Y., Lin, W. Y., Chao, T. F., Liao, J. N., Lin, Y. J., Lin, W. S., Chen, Y. J., & Chen, S. A. (2020). Management of Atrial Fibrillation in COVID-19 Pandemic. Circulation Journal, 84, 1679-1685. doi.org/10.1253/circj.CJ-20-0566
Kozlik, M., Btahuszewska, A., & Kazmierski, M. (2022). Cardiovascular System during SARS-CoV-2 Infection. International Journal of Environmental Research and Public Health, 19, 1184. doi.org/10.3390/ ijerph19031184
Li, B., Yang, J., Zhao, F., Zhi, L., Wang, X., Liu, L., Bi, Z., & Zhao, Y. (2020). Prevalence and impact of cardiovascular metabolic diseases on COVID 19 in China. Clinical Research in Cardiology, 109, 531-538. doi.org/10.1007/s00392-020-01626-9
Nishiga, M., Wang, D. W., Han, Y., Lewis, D. B., & Wu, J. C. (2020). COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. NATURE REVLEWS CARDIOLOGY, 17, 543-558. doi.org/10.1038/ s41569-020-0413-9
Peiris, S., Ordunez, P., Dipette, D., Padwal, R., Ambrosi, P., Toledo, J., Stanford, V., Lisboa, T., Aldighieri, S., & Reveiz, L. (2022). Cardiac Manifestations in Patients with COVID-19: A Scoping Review. Global Heart, 17(1). doi.org/10.5334/ gh.1037
Puntmann, V., Carerj, M., Wieters, I., Fahim, M., Arendt, C., Hoffmann, J., Shchendrygina, A., Escher, F., Nicotera, M., Zeiher, M., Vehreschild, M., & Nagel, E. (2020). Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiology, 5(11), 1265-1273. doi.org/10.1001/jamacardio.2020.3557
Roshdy, A., Zaher, S., Fayed, H., & Coghlan, G. (2021). COVID-19 and the Heart: A Systematic Review of Cardiac Autopsies. Frontiers in Cardiovascular Medicine, 7. doi.org/10.3389/fcvm.2020.626975
Ruiz, V. J. C., Montes, R. I., Puerta, J. M. P. J. M., Ruiza, C., & Rodrígueza, L. M. (2020). SARS-CoV-2 infection: The role of cytokines in COVID-19 disease. Cytokine and Growth Factor Reviews, 54, 62-75. doi.org/10.1016/j.cytogfr.2020.06.001
Sathish, T., Kapoor, N., Cao, Y., Tapp, R. J., & Zimmet, P. (2020). Proportion of newly diagnosed diabetes in COVID-19 patients: A systematic review and meta-analysis. Wiley, 23(3), 870-874. doi.org/10.1111/dom.14269
Shang, J., Wang, Q., Zhang, H., Wang, X., Wan, J., Yan, Y., & Lin, J. (2021). The relationship between diabetes mellitus and COVID-19 prognosis: a retrospective cohort study in Wuhan, China. The American Journal of Medicine, 134(1), 6-14. doi.org/10.1016/j.amjmed.2020.05.033
Siddiq, M., Chan, A., Miorin, L., Yadaw, A., Beaumont, K., Kehrer, T., Cupic, A., & Iyengara, R. (2021). Functional Effects of Cardiomyocyte Injury in COVID-19. Journal of Virology, 96(2). doi.org/10.1128/JVI.01063-21
Souza, M. T. D., Silva, M. D. D., & Carvalho, R. D. (2010). Revisão integrativa: o que é e como fazer. Einstein (São Paulo), 8, 102-106.
Stone, E., Kiat, H., & McLachlan, C. (2020). Atrial fibrillation in COVID-19: A review of possible mechanisms. The FASEB Journal, 34, 11347-11354. doi.org/10.1096/fj.202001613
Tanacli, R., Doeblin, P., Götze, C., Zieschang, V., Faragli, A., Stehning, C., Korosoglou, G., Erley, J., & Kelle, S. (2021). COVID-19 vs. Classical Myocarditis Associated Myocardial Injury Evaluated by Cardiac Magnetic Resonance and Endomyocardial Biopsy. Frontiers in Cardiovascular Medicine, 8. doi.org/10.3389/fcvm.2021.737257
Xie, Y., Xu, E., Bowe, B., & Aly, Z. A. (2022). Long-term cardiovascular outcomes of COVID-19. NATURE MEDICINE, 28, 583-590. doi.org/10.1038/s41591-022-01689-3
Yang, Y., Wei, Z., Xiong, C., & Qian, H. (2022). Direct mechanisms of SARS CoV 2 induced cardiomyocyte damage: an update. Virology, 19(1), 108. doi.org/10.1186/s12985-022-01833-y
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Felipe dos Santos Carvalho; Afonso Henrique de Queiroz Dias; Romulo Daniel Sanches ; Marcel Sebastião Junior; Fernanda Marassi; Jhon Lennon Molena; Paolla Sbardelote; Jonas Silva Pereira Amaral; Marianna Endres Moreno; Amanda Borges Cardoso
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
